- Home
- PPT vs TKNO Comparison
PPT vs TKNO Comparison
Compare PPT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPT
- TKNO
- Stock Information
- Founded
- PPT 1988
- TKNO 1996
- Country
- PPT United States
- TKNO United States
- Employees
- PPT N/A
- TKNO N/A
- Industry
- PPT Finance Companies
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- PPT Finance
- TKNO Health Care
- Exchange
- PPT Nasdaq
- TKNO Nasdaq
- Market Cap
- PPT 356.5M
- TKNO 256.9M
- IPO Year
- PPT N/A
- TKNO 2021
- Fundamental
- Price
- PPT $3.70
- TKNO $4.35
- Analyst Decision
- PPT
- TKNO
- Analyst Count
- PPT 0
- TKNO 0
- Target Price
- PPT N/A
- TKNO N/A
- AVG Volume (30 Days)
- PPT 156.1K
- TKNO 224.0K
- Earning Date
- PPT 01-01-0001
- TKNO 08-07-2025
- Dividend Yield
- PPT 8.84%
- TKNO N/A
- EPS Growth
- PPT N/A
- TKNO N/A
- EPS
- PPT N/A
- TKNO N/A
- Revenue
- PPT N/A
- TKNO $38,923,000.00
- Revenue This Year
- PPT N/A
- TKNO $9.52
- Revenue Next Year
- PPT N/A
- TKNO $15.20
- P/E Ratio
- PPT N/A
- TKNO N/A
- Revenue Growth
- PPT N/A
- TKNO 11.40
- 52 Week Low
- PPT $3.25
- TKNO $4.00
- 52 Week High
- PPT $3.72
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- PPT 54.54
- TKNO 43.35
- Support Level
- PPT $3.64
- TKNO $4.22
- Resistance Level
- PPT $3.73
- TKNO $4.94
- Average True Range (ATR)
- PPT 0.03
- TKNO 0.29
- MACD
- PPT 0.00
- TKNO -0.00
- Stochastic Oscillator
- PPT 61.11
- TKNO 16.75
About PPT Putnam Premier Income Trust
Putnam Premier Income Trust is a Massachusetts business trust operating as a non-diversified closed-end management investment company. The fund is currently operating as a diversified fund. Its investment objective is to seek high current income consistent with the preservation of capital by allocating its investments to the U.S. government sector.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.